Filing Details

Accession Number:
0001493152-24-033196
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-19 19:00:05
Reporting Period:
2024-08-15
Accepted Time:
2024-08-19 19:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1862150 Cingulate Inc. CING Pharmaceutical Preparations (2834) 863825535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1883920 Laurie Myers 1901 W. 47Th Place
Kansas City KS 66205
Evp And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-15 202 $4.17 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The number of shares reflect the 1-for-20 and the 1-for-12 reverse stock splits of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023 and August 9, 2024, respectively.